Xtrallux is a USA family-owned and operated company based in Miami, Florida. At Xtrallux, LLC, we specialize in manufacturing photobiomodulating devices for the treatment of hair loss. We serve people concerned about their hair health who may be predisposed to balding due to their family history.
Our customers expect and want the best product imaginable and we do not compromise on quality or service.
Our History
The founding team and management at Xtrallux have been in the hair restoration industry spanning 4 decades. Having worked with renowned leaders in hair restoration surgery since the 1990s, we know hair and hair loss. From pharmaceutical solutions and platelet-rich plasma therapy to follicular unit transplantation, we are well-versed in the treatment options for hair loss that exist today.
Xtrallux is not just a product, it's a commitment to ongoing hair health, recommended for its lasting benefits.
"The best type of cap is based on how many diodes the cap actually has. The more diodes, the more energy; the more energy, the more chances that you're going to be able to stop your hair loss."
Dr. Shelly Friedman
It was through Carlos's own personal experience as a hair loss patient and businessman that he first saw the potential to create an effective, convenient non-surgical product for the treatment of hair loss.
For years Carlos Piña consulted for marketing services with Miami-based, hair restoration surgeon, Dr. Bernard Nusbaum. Carlos underwent several successful hair restoration surgeries himself with Nusbaum. After learning about the advantages of light therapy to treat hair loss, Carlos invented a home-use solution utilizing cutting-edge technology in a wearable design that encourages compliance, and ultimately efficacy of results.
This first device he introduced was the CapillusPro by the company he founded, Capillus, alongside his wife and daughter. They began that company from the garage of their home in 2012 from where they designed the product, handled customer inquiries and even fulfilled their own orders.
After founding and growing the company and its brands to product lines serving various specialities, in 2021 the Piña family left Curallux (formerly Capillus) in the hands of the their partners. 1After exiting the former company, the Piña family returned to their roots and began to develop a more powerful family of devices to once again satisfy the changing needs of the hair loss market. After many months of product development, testing and setting up their new operation in Miami, Xtrallux was born.
The Xtrallux team prioritizes top-quality products and outstanding service, demonstrating their commitment to customer satisfaction.
We’re a family owned company, so we take our reputation very seriously. We want to ensure we have happy customers.
Xtrallux offers a competitively priced, comprehensive range of laser devices tailored to meet the unique hair health needs of every customer and ensuring personalized, effective hair regrowth solutions.
Available only through select providers
For Industry Professionals: Become a Provider »
Xtrallux Hair Regrowth caps are recommended for adults (men or women) who are experiencing mild to moderate hair loss due to androgenic alopecia with Fitzpatrick Skin Types I to IV as per indications for use. If your hair loss is advanced or due to scarring alopecias, this device is not right for you. Please consult with your healthcare provider for other types of hair loss (ie. medically-induced, areata, universalis, or totalis alopecias, effluvium, etc) and skin types.
Xtrallux is indicated for mild to moderate hair loss cases. If you're hair loss is advanced, you are not a candidate for laser therapy. Please read the indications for use on the product pages for detail.
Laser therapy at 650 nm and <5mW has never had any reported adverse effects for ANY skin tone, including the darkest of skin tones but due to limitations in testing protocols has only been clinically tested for treatment of AGA on skin types 1-4. Xtrallux devices are not cleared for dark skin tones due to the substantial equivalence process of FDA clearances.
Yes. The United States Food & Drug Administration has cleared Xtrallux hair regrowth devices as effective for treating androgenetic alopecia (see full indication for use). The clearance is based on substantiation by earlier submissions to the FDA providing clinical data to verify that this type of medical device emitting red laser energy results in an increase in terminal hair counts over the course of time with continued use. Terminal hair is defined as long, coarse, well-pigmented hair which differs from vellus hair.
Xtrallux manufactures devices use this technology which has been proven to increase counts of terminal hair in clinical trials accepted as substantiation by the FDA for prior clearances for this device classification.
Keep in mind that results will vary from person to person. Each case is different.
Your cart is currently empty.
Start Shopping
